SLEIPNIR clinical trial platform to test 3 Parkinson's drugs at once
Cure Parkinson’s is funding SLEIPNIR, a clinical trial platform that will simultaneously test up to three disease-modifying treatments.| Parkinson's News Today
Cure Parkinson’s is funding SLEIPNIR, a clinical trial platform that will simultaneously test up to three disease-modifying treatments.| Parkinson's News Today
